Construction and validation of a novel NAD + metabolism‐related risk model for prognostic prediction in osteosarcoma
Journal of Orthopaedic Research · 2024
DOI: 10.1002/jor.25757 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Orthopaedic Research, 2024. Verfasst von Ronghui Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Orthopedic Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China. Hauptthemen laut MEDLINE: Osteosarcoma, Bone Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangxi Province of China, Science and Technology Department of JiangXi Province.
Abstract (Originalsprache)
Currently, the prognosis of osteosarcoma (OS) remains discouraging, especially in elderly/metastatic OS patients. By impairing the antitumor effect of immune cells, tumor immune microenvironment (TIME) provides an environment conducive to tumor proliferation, which highly requires accelerated nicotinamide adenine dinucleotide (NAD + ) metabolism for energy. Recently, many genes involved in the sustained production of NAD + in malignant tumors have been verified to be possible prognostic indicators and therapeutic targets. Therefore, the current study was to probe into the association of NAD + metabolism‐related genes with TIME, immunotherapeutic response, and prognosis in OS. All OS data for the study were acquired from TARGET and GEO databases. In bioinformatics analysis, we performed Cox analysis, consensus clustering, principal component analysis, t‐distributed stochastic neighbor embedding, uniform manifold approximation and projection, gene set enrichment analysis, gene set variation analysis, Lasso analysis, survival and ROC curves, nomogram, immune‐related analysis, drug sensitivity analysis, and single‐cell RNA sequencing (scRNA‐seq) analysis. Cell transfection assay, RT‐qPCR, western blot analysis, as well as cell wound healing, migration, and invasion assays were performed in vitro. Bioinformatics analysis identified A&B clusters and six NAD + metabolism‐related differentially expressed genes, constructed risk model and nomogram, and performed immune‐related analysis, drug susceptibility analysis, and scRNA‐seq analysis to inform the clinical treatment framework. In vitro experiment revealed that CBS and INPP1 can promote migration, proliferation as well as invasion of OS cells through TGF‐β1/Smad2/3 pathway. Based on bioinformatics analysis and in vitro validation, this study confirmed that NAD + metabolism affects TIME to suggest the prognosis of OS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Orthopedic Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
- Department of Orthopedics, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Department of Cardiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
- Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Department of Orthopedics, Jiangxi Provincial Children's Hospital, Nanchang, Jiangxi, China.
ORCID-Profile: Xia Lan
Förderung
- Natural Science Foundation of Jiangxi Province of China
- Science and Technology Department of JiangXi Province
Zitieren
APA
Yu, R., Lu, G., Cheng, B., Li, J., Jiang, Q., & Lan, X. (2024). Construction and validation of a novel NAD + metabolism‐related risk model for prognostic prediction in osteosarcoma. Journal of Orthopaedic Research. https://doi.org/10.1002/jor.25757
Vancouver
Yu R, Lu G, Cheng B, Li J, Jiang Q, Lan X. Construction and validation of a novel NAD + metabolism‐related risk model for prognostic prediction in osteosarcoma. Journal of Orthopaedic Research. 2024. doi:10.1002/jor.25757
BibTeX
@article{Yu2024,
author = {Yu, Ronghui and Lu, Gang and Cheng, Banghong and Li, Junhong and Jiang, Qiqing and Lan, Xia},
title = {Construction and validation of a novel NAD + metabolism‐related risk model for prognostic prediction in osteosarcoma},
journal = {Journal of Orthopaedic Research},
year = {2024},
doi = {10.1002/jor.25757}
}
EUVIMED